DOST logs 35 qualified participants in VCO study in Valenzuela City

Published June 18, 2021, 11:16 PM

by Charissa Luci-Atienza 

A total of 35 individuals have been qualified to undergo the Department of Science and Technology-Food and Nutrition Research Institute’s (DOST-FNRI) “randomized double-blind controlled intervention trial” on virgin coconut oil (VCO) in Valenzuela City.


This was announced by DOST Secretary Fortunato “Boy” T. de la Peña on the DOSTv Facebook page on Friday, June 18.

The DOST-FNRI VCO study seeks to evaluate the beneficial effect of virgin coconut oil given to suspect and probable cases of coronavirus disease (COVID-19) who are quarantined in a center or hospital.

“As of June 4, 2021, the ongoing project “Beneficial effects of VCO tested among suspect and probable cases of COVID-19” being implemented in Valenzuela City has 35 qualified subjects out of the 120 target participants,” he said.

Of the 35 “qualified” participants, “10 are still undergoing intervention, while 19 have graduated or completed the program,” he noted.

The DOST chief said there were six participants who have withdrawn and did not complete the intervention.

DOST-FNRI Director Dr. Imelda Angeles Agdeppa is leading the intervention trial, which is implemented on May 1, 2020 to June 31, 2021.

She bared last month that they asked the management of the Ospital ng Muntinlupa to allow its hospital to serve as site for their ongoing study.

De la Peña had noted that based on the VCO study in Santa Rosa, Laguna, result showed that meals mixed with VCO could reduce COVID-19 symptoms in suspect and probable cases, thus, possibly preventing the progression or severity of the disease.

In December 2020, the FNRI team reported the effectiveness of VCO on 57 probable and suspected cases at the Santa Rosa Community Quarantine Facility and in Santa Rosa Community Hospital.

Results of the FNRI study on VCO as dietary supplement among COVID-19 probable and suspect cases showed that “five of the 29 patients who were served meals with VCO manifested diminishing signs and symptoms as early as the second day, while only one patient served with the same meals but without VCO showed similar improvement.”

The VCO group of patients who were served meals with VCO showed no COVID-19 related symptoms at Day 18, while symptoms persisted in some patients of the Control Group of patients who were served the same meals without VCO until Day 23, it showed.